Stay updated on Safety of Iptacopan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety of Iptacopan in IgA Nephropathy Clinical Trial page
- Check2 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check9 days agoChange DetectedA site-wide NIH notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The trial record details are unchanged.SummaryDifference0.5%

- Check16 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check23 days agoChange DetectedThe clinical trial record now lists the study as recruiting, replacing its previous status of active but not recruiting. The record was updated on 2026-10-05.SummaryDifference0.8%

- Check44 days agoChange DetectedA new revision entry v3.7.0 was added to the record history, and the previous v3.6.6 entry was removed, indicating an update to the page's versioning.SummaryDifference0.1%

- Check65 days agoChange DetectedA new revision entry (v3.6.6) was added to the record history and the previous entry (v3.6.5) was removed from the list. This update reflects a posted new version of the study record and its version tracking.SummaryDifference0.1%

Stay in the know with updates to Safety of Iptacopan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.